CHICAGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Alliance Creative Group, Inc. (http://www.ACGX.us) (OTC: ACGX) is pleased to announce the successful closing of its acquisition of multiple digital media assets, effective September 30, 2025. Through this transaction, ACGX has acquired: 12 Domains spanning industries including Gaming, Medical, Tourism, Home Décor, Hair & Beauty, and Entertainment.57 Social Media Pages across TikTok, Instagram, Twitter/X, YouTube, Facebook, and Pinterest.A combined 14+ million mont ...

Accessibility StatementSkip Navigation BOUND BROOK, N.J., Sept. 22, 2025 /PRNewswire/ -- SR Bancorp, Inc. (NASDAQ: SRBK), the holding company for Somerset Regal Bank, announced that its Board of Directors has declared the payment of a quarterly cash dividend. The dividend of $0.05 per share will be paid on October 15, 2025 to stockholders of record as of September 30, 2025. David Orbach, Executive Chairman of SR Bancorp, Inc said: "We are pleased to be in a strong financial position giving us the ability t ...

ZUG, Switzerland and BOSTON and SAN DIEGO and SHANGHAI, Sept. 22, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Sirius Therapeutics, a clinical stage biotech company developing innovative small interfering RNA (siRNA) therapies for global markets, today announced that the first patient has been dosed in a Phase 2 clinical trial of SRSD107, a next-generation, long-acting Factor XI (FXI ...

When I last covered Meta Platforms, Inc. (NASDAQ: META ) on April 15th, 2025, with my article "Meta Platforms: Stock Collapses, Here's When To Buy”, the stock was encountering severe declines and nearing the bottom of what wouldThe Income Machine is driven by market analysis from strategies covering more than two decades of trading experience successfully navigating through a broad range of asset classes. I am @PROSTOCKMARKETS on YouTube, which is where I post daily video updates for all of my trades and de ...

DALLAS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Triumph (NYSE: TFIN), a financial and technology company focused on payments, factoring, intelligence and banking solutions for the transportation industry, has launched its integrated Pricing and Performance Intelligence solution. This launch marks the first step in unifying pricing, performance and capacity sourcing into a single, trusted data solution for freight brokers. As part of the rollout, Triumph is introducing sourcing capabilities by embedding carrier c ...

Accessibility StatementSkip Navigation MINNEAPOLIS, Sept. 22, 2025 /PRNewswire/ -- Target Corporation (NYSE: TGT)Â received notice of an unsolicited mini-tender offer by TRC Capital Corporation ("TRC Capital") to purchase up to 1,500,000 shares of Target's common stock at a price of $89.00 per share in cash, without interest. The offer is for approximately 0.33 percent of the outstanding shares of Target's common stock. Target is not affiliated with TRC Capital and does not endorse this unsolicited mini-ten ...

OKEMOS, MI / ACCESS Newswire / September 22, 2025 / Tianrong Medical Group Inc. (OTC:TNMD), transforming into a tokenized, publicly traded real estate investment trust (REIT), today announced it has secured a premier oceanfront parcel in Hopkins Village, Stann Creek District, Belize for the development of its flagship luxury resort project. This milestone positions Tianrong at the forefront of global real estate innovation, pairing a world-class Caribbean destination with a pipeline of high-demand residenti ...

Core Insights - NetraMark Holdings Inc. has announced a collaboration focused on glioblastoma (GBM) research, utilizing proprietary know-how and access to clinical and biomarker datasets from a leading U.S. academic medical center [1][5] Group 1: Collaboration and Objectives - The collaboration aims to apply NetraAI, the company's explainable AI platform, to identify patient subgroups for developing a therapeutic decision support tool for future GBM trials [2] - Specific objectives include generating insights from longitudinal cerebrospinal fluid (CSF) proteomic datasets and creating NetraPersonas to optimize trial enrichment strategies [4][5] Group 2: Glioblastoma Challenges - Glioblastoma is characterized by a median survival of just 15 months, with less than 7% of patients surviving beyond five years, and clinical trials have a failure rate exceeding 90% due to heterogeneous patient populations and limited predictive biomarkers [3] Group 3: Data Utilization and Analysis - The academic partner will provide expanded longitudinal glioblastoma proteomic datasets generated on the SomaLogic platform, which will be analyzed to identify molecular markers and understand treatment impacts [5][7] - NetraAI's unique focus mechanisms allow for the separation of small datasets into explainable and unexplainable subsets, enhancing the potential for accurate insights and reducing the risk of overfitting [6][8]

Accessibility StatementSkip Navigation Presentations from 5 Key Opinion Leaders on ProSense® cryoablation including 3 independent studies on breast cancer and 1 on endometriosis   3 hands-on training sessions for doctors interested in using ProSense® were very well attended Dedicated CIRSE focus session on the breast shows the growing interest from interventional radiologists to expand their practice to include care for breast cancer patients CAESAREA, Israel, Sept. 22, 2025 /PRNewswire/ -- IceCure Medic ...

JACKSON, WY / ACCESS Newswire / September 22, 2025 / Labor Smart, Inc. (OTCID:LTNC) today announced a consulting agreement with Ernesto Amador, internationally renowned sports broadcaster and cultural figure. Amador, who recently served as the Spanish-language voice for Netflix's historic Canelo Ãlvarez vs. ...